SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 71 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,590,000 | +77.0% | 470,000 | +22.1% | 2.45% | +74.4% |
Q2 2016 | $1,463,000 | +32.5% | 385,000 | -3.8% | 1.40% | +25.1% |
Q1 2016 | $1,104,000 | +36.6% | 400,000 | +180.7% | 1.12% | +7.3% |
Q4 2015 | $808,000 | +103.5% | 142,500 | +90.0% | 1.05% | +55.3% |
Q3 2015 | $397,000 | +32.3% | 75,000 | +107.2% | 0.67% | +102.4% |
Q2 2015 | $300,000 | +29.9% | 36,200 | -27.6% | 0.33% | +41.7% |
Q1 2015 | $231,000 | +312.5% | 50,000 | +150.0% | 0.24% | +434.1% |
Q3 2014 | $56,000 | -93.9% | 20,000 | -91.1% | 0.04% | -93.3% |
Q2 2014 | $915,000 | -31.0% | 225,000 | -10.0% | 0.66% | -40.8% |
Q1 2014 | $1,327,000 | -5.7% | 250,000 | 0.0% | 1.12% | -1.8% |
Q4 2013 | $1,407,000 | – | 250,000 | – | 1.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |